Evolutionary Genomics, Inc. — Operating Income by Fiscal Year
13 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/c92b4a9e-4571-444a-996d-4f856c5e5e64/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2022 | $-2.0M | 2022-01-01 – 2022-12-31 | evidence 0001553350-23-000160 |
| FY 2021 | $-2.9M | 2021-01-01 – 2021-12-31 | evidence 0001553350-22-000231 |
| FY 2020 | $-2.9M | 2020-01-01 – 2020-12-31 | evidence 0001553350-21-000252 |
| FY 2019 | $-774.8k | 2019-01-01 – 2019-12-31 | evidence 0001553350-20-000255 |
| FY 2018 | $-836.8k | 2018-01-01 – 2018-12-31 | evidence 0001553350-19-000304 |
| FY 2017 | $-1.3M | 2017-01-01 – 2017-12-31 | evidence 0001553350-18-000184 |
| FY 2016 | $-1.1M | 2016-01-01 – 2016-12-31 | evidence 0001553350-17-000164 |
| FY 2015 | $-722.9k | 2015-01-01 – 2015-12-31 | evidence 0001553350-16-001601 |
| FY 2014 | $-990.4k | 2014-01-01 – 2014-12-31 | evidence 0001553350-16-001601 |
| FY 2013 | $-99.3k | 2008-08-01 – 2014-03-31 | evidence 0001553350-14-000496 |
| FY 2012 | $-86.0k | 2008-08-01 – 2013-03-31 | evidence 0001553350-13-000198 |
| FY 2011 | $76.9k | 2008-08-01 – 2012-03-31 | evidence 0001269678-12-000008 |
| FY 2010 | $-23.5k | 2010-01-01 – 2010-12-31 | evidence 0001269678-12-000004 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Evolutionary Genomics, Inc. — all facts · Revenue · Net Income